Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:696-701
Published online before print January 8, 2009, doi: 10.1161/STROKEAHA.108.525733
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/696    most recent
STROKEAHA.108.525733v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bevan, S.
Right arrow Articles by Markus, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bevan, S.
Right arrow Articles by Markus, H. S.
Related Collections
Right arrow Genetics of Stroke
Right arrow Genetics of cardiovascular disease

(Stroke. 2009;40:696.)
© 2009 American Heart Association, Inc.


Original Contributions

Genetic Variation in the Leukotriene Pathway and Carotid Intima-Media Thickness

A 2-Stage Replication Study

Steve Bevan, BSc, PhD; Matthias W Lorenz, MD; Matthias Sitzer, MD Hugh S. Markus, FRCP

From Clinical Neuroscience (S.B., H.S.M.), St. George’s University of London, London, UK; Department of Neurology (M.W.L., M.S.), Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.

Correspondence to Steve Bevan, Clinical Neuroscience, St. Georges University of London, Cranmer Terrace, Tooting, London SW17 0RE. E-mail sbevan{at}sgul.ac.uk

Background and Purpose— The recent finding that genetic variation in the leukotriene biosynthesis pathway may confer an increased risk of ischemic stroke and atherosclerosis has implicated the leukotriene family as potential mediators of cardiovascular disease. Using a 2-stage replication design, we have examined whether polymorphisms in 8 genes related to this pathway are associated with early atherosclerosis and remodeling as measured by carotid artery intima-media thickness.

Methods— We assessed 969 individuals from the Carotid Atherosclerosis Progression Study (CAPS), a community based study of normal subjects, for 39 variants in the leukotriene pathway. Significant associations and gene–environment interactions were found for 21 variants in the initial cohort and were examined in the next 1905 consecutive cases from the same CAPS population.

Results— No replicable association between any individual polymorphism and carotid intima-media thickness itself was present after correction for multiple testing. A single gene–environment interaction was replicated between rs17222814 on bifurcation intima-media thickness and alcohol consumption exceeding 30 grams per day.

Conclusion— The genetic variants we examined in the leukotriene biosynthesis pathway have little effect on early atherosclerosis and remodeling risk as determined by carotid intima-media thickness. Our study cannot exclude them as being risk factors for more advanced stages in the atherosclerotic process.


Key Words: atherosclerosis • genetics